Cargando…
The Incidence and Risk Factors for Adverse Drug Reactions Related to Tanreqing Injection: A Large Population-Based Study in China
Background: Tanreqing injection (TRQ) is a traditional Chinese medicine commonly used in China to treat pulmonary diseases presenting as phlegm-heat syndrome. Robust data on the safety of TRQ from real-world observational cohorts are currently lacking. Objective: To evaluate as the incidence, type,...
Autores principales: | Li, Xiao-Xiao, Zhuo, Lin, Zhang, Yan, Yang, Yi-Heng, Zhang, Hong, Zhan, Si-Yan, Zhai, Suo-Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962140/ https://www.ncbi.nlm.nih.gov/pubmed/31998127 http://dx.doi.org/10.3389/fphar.2019.01523 |
Ejemplares similares
-
The Effect of Tanreqing Injection on the Pharmacokinetics of Sirolimus in Rats
por: Zhang, Feng, et al.
Publicado: (2019) -
Pharmacokinetics of baicalin and oroxyloside in plasma and different tissues of rats after transnasal aerosol inhalation and intravenous injection of Tanreqing
por: Chen, Teng-Fei, et al.
Publicado: (2022) -
Pharmacokinetic study of the main components of Tanreqing capsules and Tanreqing injections in beagles by liquid chromatography–tandem mass spectrometry
por: Cui, Lili, et al.
Publicado: (2022) -
Better response to Tanreqing injection in frequent acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients—Real-world evidence from a nationwide registry (ACURE) study
por: Fan, Guohui, et al.
Publicado: (2023) -
Tanreqing Inhibits LPS-Induced Acute Lung Injury In Vivo and In Vitro Through Downregulating STING Signaling Pathway
por: He, Yu-Qiong, et al.
Publicado: (2021)